2017 may become a very exciting year for Patricia Biasutto, sepofarsen captain. Her work, developing a novel RNA therapy for Leber congenital amaurosis 10, has progressed steadily. The team expects to start a first clinical trial this year.
… during the Foundation Fighting Blindness/Casey Innovation summit prior to ARVO. LEIDEN, the Netherlands, … Ophthalmology Franchise of ProQR Session: FFB/Casey Innovation summit prior to ARVO: Retinal Cell and Gene …
